Evidence map›Paper›PMID 14647975›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2003

Influence of alpha2-autoreceptor stimulation on the facilitation by angiotensin II and bradykinin of noradrenaline release.

Alberto Mota, Serafim Guimarães

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Alberto MotaInstituto de Farmacologia e Terapêutica, Faculdade de Medicina do Porto, Alameda Prof. Hernâni Monteiro, 4200-319, Porto, Portugal. avmota@yahoo.com
Serafim Guimarães

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The interaction between alpha(2)-autoreceptors and receptors for angiotensin II and bradykinin was studied in the heart of newborn rats. The tissues were labeled with [3H] noradrenaline and then superfused with cocaine-containing medium and stimulated electrically. Angiotensin II (30-1,000 nM) and bradykinin (10-300 nM) enhanced the evoked overflow of tritium, the maximum increase reaching 52.2 and 72.8%, respectively. In the presence of the selective alpha(2)-adrenoceptor agonist UK-14,304, the maximal effect caused by angiotensin II and bradykinin was enhanced reaching 92.1 and 87.1% for angiotensin II and bradykinin, respectively. On the contrary, in the presence of chelerythrine (a protein kinase C blocker), not only the increment in facilitation by UK-14,304, but to some extent also the basal facilitation caused by angiotensin II and bradykinin were markedly reduced (to 17.3 and 43.2%, respectively). We conclude that: 1. The stimulation of alpha2-autoreceptors enhances the facilitatory responses caused by angiotensin II and bradykinin, confirming that an ongoing alpha2-autoinhibition is required for the facilitatory influence of the peptides. 2. Protein kinase C is involved in the enhancement by angiotensin II and bradykinin of electrically-evoked release of noradrenaline from the nerve terminals.

Indexed as

Adrenergic alpha-2 Receptor AgonistsAdrenergic alpha-AgonistsAlkaloidsAngiotensin IIAnimalsAnimals, NewbornAutoreceptorsBenzophenanthridinesBradykininBrimonidine TartrateDrug SynergismElectric StimulationEnzyme InhibitorsHeartIn Vitro TechniquesNorepinephrineAdrenergic alpha-2 Receptor AgonistsAdrenergic alpha-AgonistsAlkaloidsAngiotensin IIAutoreceptorsBenzophenanthridinesBradykininBrimonidine TartratechelerythrineEnzyme InhibitorsNorepinephrinePhenanthridinesProtein Kinase CQuinoxalines

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.